The oral gonadotropin-releasing hormone antagonist elagolix substantially decreased excessive menstrual bleeding for women with uterine fibroids, according to findings published in The New England Journal of Medicine.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.